Gentherm Reports 2023 Third Quarter Results

Oct 26, 2023

Delivered Highest Quarterly Adjusted EBITDA in Ten Quarters
Secured $520M in New Automotive Business Awards, a Third Quarter Record
Updates 2023 Guidance

NORTHVILLE, Mich., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced its financial results for the third quarter ending September 30, 2023.

Third Quarter Highlights

  • Product revenues of $366.2 million increased 10.0% from $333.0 million in the third quarter of 2022. Excluding the impact of foreign currency translation, product revenues increased 8.5% year over year
  • Automotive revenues increased 10.0% year over year; excluding the impact of foreign currency translation and contributions from the Alfmeier acquisition, increased 3.1% year over year
  • GAAP diluted earnings per share was $0.48 as compared with $0.29 for the prior year period
  • Adjusted diluted earnings per share (1) was $0.64. Adjusted diluted earnings per share in the prior year period was $0.70
  • Secured new automotive business awards totaling $520 million in the quarter
  • Repurchased $11.1 million of the Company’s common stock

         (1)    We provide adjusted diluted earnings per share and other non-GAAP financial measures in this release. 
                 See “Use of Non-GAAP Measures” below for additional information, including definitions, usefulness for
                 investors and limitations, as well reconciliations below to the most directly comparable GAAP financial
                 measures.

Phil Eyler, the Company's President and CEO, said, “I am pleased with the continued strong execution by the global Gentherm team, enabling us to deliver record quarterly Climate Control Seat and Steering Wheel Heaters revenues as well as the highest quarterly Adjusted EBITDA in ten quarters. In addition, we secured $520 million in new automotive business awards in the third quarter, including a breakthrough multi-function electronic control unit award from General Motors. We also recently won our first combined thermal and pneumatic massage comfort award with Li Auto, one of the rising EV manufacturers in China.

He concluded: “While the automotive production environment remains challenging including the UAW strike, our relentless focus on strong operational execution, innovation and cash flow generation along with our record performance on new business awards position us well to continue to drive shareholder value over the long term.”

2023 Third Quarter Financial Review

Product revenues for the third quarter of 2023 increased by $33.2 million, or 10.0%, as compared with the prior year period. Excluding the impact of foreign currency translation, product revenues increased 8.5% year over year.

Automotive revenues increased 10.0% year over year as a result of the contribution from Alfmeier, as well as record quarterly revenues in Climate Control Seat and Steering Wheel Heaters, partially offset by decreased revenue in Electronics, Battery Performance Solutions and Other Automotive product categories year-over-year. Adjusting for foreign currency translation and excluding the contribution from Alfmeier, organic Automotive revenues increased 3.1% year over year. According to S&P Global Mobility’s mid-October report, actual light vehicle production increased by 4.6% in the current year’s third quarter when compared with the third quarter of 2022 in the Company’s key markets of North America, Europe, China, Japan and Korea.

Gentherm Medical revenue increased 9.7% year over year, primarily as a result of increased revenues from its Dacheng air warming blankets.

See the “Revenues by Product Category” table included below for additional detail.

Gross margin rate decreased to 23.5% in the current year period, as compared with 24.1% in the prior year period. The decrease from the prior year period resulted from the acquired Alfmeier business having a lower gross margin rate relative to the Company’s organic Automotive business, non-automotive electronics inventory charge, material and wage inflation, and lower price recoveries from customers. These were partially offset by lower freight costs, increased productivity at the factories, and fixed cost leverage from higher unit volume.

Net research and development expenses of $23.2 million in the third quarter increased $0.5 million, or 2.1% over the prior year period, primarily as a result of the additional expenses from the Alfmeier business, partially offset by higher customer reimbursements for research and development expenses.

Selling, general and administrative expenses of $38.2 million in the third quarter increased $3.4 million, or 9.6%, versus the prior year period. The year-over-year increase was primarily driven by additional expenses from the acquired businesses and higher compensation expenses.

Acquisition and integration expenses of $1.6 million in the current year period were $9.7 million lower than the prior year period as a result of reduced expenses associated with the Alfmeier acquisition. Restructuring expenses were $1.1 million in the current year period.

As described more fully in the “Reconciliation of Net Income to Adjusted EBITDA” table included below, the Company recorded Adjusted EBITDA of $47.7 million in the 2023 third quarter compared with $41.6 million in the prior year period, an increase of $6.1 million or 14.6%.

Income tax expense in the third quarter was $6.9 million, as compared with $5.8 million in the prior year period. The effective tax rate was 30.4% in the 2023 third quarter.

GAAP diluted earnings per share for the third quarter was $0.48 compared with earnings per share of $0.29 for the prior year period. Adjusted diluted earnings per share, excluding non-automotive electronics inventory charge, acquisition and integration expenses, restructuring expenses, and unrealized currency gain (see table herein), was $0.64. Adjusted diluted earnings per share in the prior year period was $0.70.

Guidance

The Company updates its full year 2023 guidance that was initially provided in its year-end 2022 earnings release on February 22, 2023:

 
  Revised Outlook for FY 2023   Prior Outlook
 
  Low   High   Low   High
 
Product revenues (1)(2) $1.45B   $1.47B   $1.45B   $1.55B  
Adjusted EBITDA Margin Rate (3) 11.5%   12.5%   11.5%   13.5%  
Full-year Adjusted Effective Tax Rate (4) 28%   32%   28%   32%  
Capital Expenditures $40M   $50M   $60M   $70M  
 
(1)   Based on the current forecast of customer orders, inflation and pricing recovery, and a EUR to USD exchange rate
        of $1.05/Euro
(2)   Assumes OEM plants impacted by the UAW strike as of October 25th will remain idled through the end of November
(3)   Starting with 2023 reporting, the Company excludes the impact of non-cash stock-based compensation from the
        Adjusted EBITDA results
(4)   Excluding the impact of non-cash goodwill impairment on earnings before income tax of $19.5 million reported in the
        second quarter of 2023, which includes the associated deferred tax effect, and income tax benefit of $2.4 million.
 

Conference Call

As previously announced, Gentherm will conduct a conference call today at 8:00 am Eastern Time to review these results. The dial-in number for the call is 1-877-407-4018 (callers in the U.S.) or +1-201-689-8471 (callers outside this U.S.). The passcode for the live call is 13741956.
A live webcast and one-year archived replay of the call can be accessed on the Events page of the Investor section of Gentherm's website at www.gentherm.com.

A telephonic replay will be available approximately two hours after the call until 11:59 pm Eastern Time on November 9, 2023. The replay can be accessed by dialing 1-844-512-2921 (callers in the U.S.), or +1-412-317-6671 (callers outside the U.S.). The passcode for the replay is 13741956.

Investor Contact 
Yijing Brentano 
investors@gentherm.com
248.308.1702 

Media Contact
Melissa Fischer
media@gentherm.com
248.289.9702

About Gentherm
Gentherm (NASDAQ: THRM) is the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems. Automotive products include variable temperature Climate Control Seats, heated automotive interior systems (including heated seats, steering wheels, armrests and other components), battery performance solutions, cable systems, lumbar and massage comfort solutions, valve system technologies, and other electronic devices. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities in the United States, Germany, China, Czech Republic, Hungary, Japan, Malta, Mexico, North Macedonia, South Korea, United Kingdom, Ukraine, and Vietnam. For more information, go to www.gentherm.com.

Forward-Looking Statements 

Except for historical information contained herein, statements in this release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent Gentherm Incorporated's goals, beliefs, plans and expectations about its prospects for the future and other future events. The forward-looking statements included in this release are made as of the date hereof or as of the date specified herein and are based on management's reasonable expectations and beliefs. Such statements are subject to a number of important assumptions, significant risks and uncertainties (some of which are beyond our control) and other factors that may cause actual results or performance to differ materially from that described in or indicated by the forward-looking statements, including but not limited to:

  • macroeconomic, geopolitical and similar global factors on the cyclical Automotive industry;
  • the production levels of our major customers and OEMs in our key markets and sudden fluctuations in such production levels, in particular with respect to models for which we supply significant amounts of product;
  • our ability to integrate our recent acquisitions and realize synergies, as well as to consummate additional strategic acquisitions, investments and exits;
  • our implementation activities to execute our long-term strategy of Fit-for-Growth 2.0, including profitability improvement and cost reductions;
  • our ability to effectively manage new product launches and research and development;
  • increasing competition, including with non-traditional entrants;
  • the ongoing supply-constrained environment, including raw material and component shortages, manufacturing disruptions and delays, logistics challenges, inflationary and other cost pressures;
  • the impact of our global operations, including our global supply chain, operations within Ukraine, economic and trade policies by various jurisdictions, and foreign currency risk and foreign exchange exposure;
  • our business in China, which is subject to unique operational, competitive, regulatory and economic risks;
  • a tightening labor market, labor shortages or work stoppages impacting us, our customers or our suppliers, including the potential impact of ongoing and future labor strikes among certain OEMs and suppliers;
  • our achievement of product cost reductions to offset customer-imposed price reductions or other pricing pressures;
  • any security breaches and other disruptions to our information technology networks and systems, as well as privacy, data security and data protection risks;
  • our product quality and safety;
  • the evolution of the automotive industry towards electric vehicles, autonomous vehicles and mobility on demand services, and related consumer behaviors and preferences;
  • the development of and market acceptance of our existing and future products;
  • our borrowing availability under our revolving credit facility, as well as our ability to access the capital markets, to support our planned growth;
  • our indebtedness and compliance with our debt covenants;
  • the effects of climate change and catastrophic events, as well as regulatory and stakeholder-imposed requirements to address climate change and other sustainability issues;
  • our efforts to optimize our global supply chain and manufacturing footprint;
  • our ability to project future sales volume based on third-party information, based on which we manage our business;
  • our ability to convert new business awards into product revenues;
  • any loss or insolvency of our key customers and OEMs, or key suppliers;
  • risks associated with our manufacturing processes;
  • the extensive regulation of our patient temperature management business;
  • the protection of our intellectual property in certain jurisdictions;
  • our compliance with anti-corruption laws and regulations; and
  • legal and regulatory proceedings and claims involving us or one of our major customers.

The foregoing risks should be read in conjunction with the Company's reports filed with or furnished to the Securities and Exchange Commission (the “SEC”), including “Risk Factors,” in its most recent Annual Report on Form 10-K and subsequent SEC filings, for a discussion of these and other risks and uncertainties. In addition, with reasonable frequency, we have entered into business combinations, acquisitions, divestitures, strategic investments and other significant transactions. Such forward-looking statements do not include the potential impact of any such transactions that may be completed after the date hereof, each of which may present material risks to the Company’s future business and financial results.

Except as required by law, the Company expressly disclaims any obligation or undertaking to update any forward-looking statements to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

 
GENTHERM INCORPORATED
CONSOLIDATED CONDENSED STATEMENTS OF INCOME
(In thousands, except per share data)
(Unaudited)
 
  Three Months Ended
September 30,

  Nine Months Ended
September 30,

 
  2023
  2022
  2023
  2022
 
Product revenues $ 366,195     $ 332,962     $ 1,102,143     $ 861,334    
Cost of sales   279,985       252,610       846,815       657,492    
Gross margin   86,210       80,352       255,328       203,842    
Operating expenses:                                
Net research and development expenses   23,150       22,666       72,991       62,425    
Selling, general and administrative expenses   38,220       34,859       113,680       96,109    
Impairment of goodwill               19,509          
Restructuring expenses   1,099       6       3,412       561    
   Total operating expenses   62,469       57,531       209,592       159,095    
Operating income   23,741       22,821       45,736       44,747    
Interest (expense) income, net   (3,368 )     714       (9,444 )     (1,285 )  
Foreign currency gain (loss)   2,107       (8,285 )     384       (1,516 )  
Other income   272       361       1,058       698    
Earnings before income tax   22,752       15,611       37,734       42,644    
Income tax expense   6,908       5,784       15,478       13,998    
Net income $ 15,844     $ 9,827     $ 22,256     $ 28,646    
Basic earnings per share $ 0.48     $ 0.30     $ 0.67     $ 0.87    
Diluted earnings per share $ 0.48     $ 0.29     $ 0.67     $ 0.86    
Weighted average number of shares – basic   32,944       33,162       33,049       33,106    
Weighted average number of shares – diluted   33,196       33,470       33,311       33,460    
 


 
GENTHERM INCORPORATED
REVENUE BY PRODUCT CATEGORY AND RECONCILIATION OF FOREIGN CURRENCY
TRANSLATION IMPACT
(In thousands)
(Unaudited)
 
  Three Months Ended September 30,
  Nine Months Ended September 30,
 
  2023
  2022
  % Change   2023
  2022
  % Change
 
Climate Control Seat $ 124,905     $ 112,059       11.5 %   $ 360,868     $ 311,281       15.9 %  
Seat Heaters   77,238       75,568       2.2 %     231,132       210,367       9.9 %  
Steering Wheel Heaters   39,861       31,482       26.6 %     115,166       89,169       29.2 %  
Lumbar and Massage Comfort
Solutions (a)
  33,260       22,740       46.3 %     109,602       22,740       382.0 %  
Valve Systems (a)   27,830       18,542       50.1 %     82,516       18,542       345.0 %  
Automotive Cables   19,668       18,338       7.3 %     60,131       59,662       0.8 %  
Battery Performance Solutions   17,242       20,331       (15.2 )%     57,138       55,395       3.1 %  
Electronics   10,163       12,083       (15.9 )%     30,456       33,190       (8.2 )%  
Other Automotive   4,615       11,412       (59.6 )%     21,998       29,224       (24.7 )%  
Subtotal Automotive
segment
  354,782       322,555       10.0 %     1,069,007       829,570       28.9 %  
Medical segment (b)   11,413       10,407       9.7 %     33,136       31,764       4.3 %  
Total Company $ 366,195     $ 332,962       10.0 %   $ 1,102,143     $ 861,334       28.0 %  
                                                 
Foreign currency translation
impact (c)
  4,825                     (4,962 )                
Total Company, excluding
foreign
currency translation impact
$ 361,370     $ 332,962       8.5 %   $ 1,107,105     $ 861,334       28.5 %  
 
(a) Represents product revenues from Alfmeier (acquired on August 1, 2022).
(b) Includes product revenues of $1,988 and $4,939 for the three and nine months ended September 30, 2023,
respectively, and $1,234 for the three and nine months ended September 30, 2022 from Dacheng (acquired on July
13, 2022).
(c) Foreign currency translation impacts for the Automotive segment and Medical segment were $4,654 and $171,
respectively, for the three months ended September 30, 2023. Foreign currency translation impacts for the
Automotive segment and Medical segment were $(4,843) and $119, respectively, for the nine months ended
September 30, 2023.
 


 
GENTHERM INCORPORATED
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA
(In thousands)
(Unaudited)
 
  Three Months Ended
September 30,

  Nine Months Ended
September 30,

 
  2023
  2022
  2023   2022
 
Net income $ 15,844     $ 9,827     $ 22,256     $ 28,646    
Add back:                                
Depreciation and amortization   12,516       11,774       38,354       30,259    
Income tax expense (a)   6,908       5,784       15,478       13,998    
Interest expense (income), net (b)   3,368       (714 )     9,444       1,285    
Adjustments:                                
Impairment of goodwill               19,509          
Non-cash stock-based compensation (c)   3,421       (1,568 )     8,592       4,622    
Acquisition and integration expenses   1,618       11,349       4,730       18,357    
Restructuring expense   1,099       6       3,412       561    
Non-automotive electronics inventory charge   3,426             5,489          
Unrealized currency (gain) loss   (898 )     5,308       4,227       (1,032 )  
Other   372       (157 )     71       (483 )  
Adjusted EBITDA $ 47,674     $ 41,609     $ 131,562     $ 96,213    
                                 
Product revenues $ 366,195     $ 332,962     $ 1,102,143     $ 861,334    
Adjusted EBITDA Margin   13.0 %     12.5 %     11.9 %     11.2 %  
 
(a) Includes $2,423 of deferred income tax benefit associated with the goodwill impairment of the Medical Reporting
Unit for the nine months ended September 30, 2023.
(b) Includes $62 and $734 of interest income for the three months and nine months ended September 30, 2023,
related to mark-to-market adjustment of our floating-to-fixed interest rate swap agreement with a notional amount of
$100,000.
(c) Includes operating expenses of $3,384 and $(1,933) for the three months ended September 30, 2023 and 2022,
respectively. Includes operating expenses of $8,218 and $4,506 for the nine months ended September 30, 2023 and
2022, respectively.
 


 
  Three Months
Ended
September 30,

  Nine Months
Ended
September 30,

 
  2022
  2022
 
Adjusted EBITDA $ 41,609     $ 96,213    
Non-cash stock-based compensation   1,568       (4,622 )  
Adjusted EBITDA as reported in Q3 2022 (1) $ 43,177     $ 91,591    
Adjusted EBITDA Margin as reported in Q3 2022 (1)   13.0 %     10.6 %  
 
(1) Includes the impact of non-cash stock-based compensation
 
  Three Months
Ended
September 30,

  Nine Months
Ended
September 30,

 
  2022
  2022
 
Adjusted EBITDA $ 41,609     $ 96,213    
Pro forma EBITDA impact of Alfmeier acquisition   603       2,425    
Pro forma Adjusted EBITDA $ 42,212     $ 98,638    
Pro forma Adjusted EBITDA Margin   12.0 %     9.8 %  
 
  Three Months
Ended
September 30,

  Nine Months
Ended
September 30,

 
  2022
  2022
 
Product revenues $ 332,962     $ 861,334    
Pro forma revenue impact of Alfmeier acquisition   19,915       143,640    
Pro forma product revenues $ 352,877     $ 1,004,974    
 


 
  Adjusted
EBITDA

as reported (1)
  Non-Cash
Stock-based
Compensation

  Adjusted
EBITDA
(1)
  Product
Revenues

  Adjusted
EBITDA
Margin
(1)
 
Three months ended September 30, 2023 $ -     $ -     $ 47,674     $ 366,195       13.0 %  
Three months ended June 30, 2023   -       -       42,378       372,323       11.4 %  
Three months ended March 31, 2023   -       -       41,510       363,625       11.4 %  
Three months ended December 31, 2022   38,178       2,771       40,949       343,322       11.9 %  
Three months ended September 30, 2022   43,177       (1,568 )     41,609       332,962       12.5 %  
Three months ended June 30, 2022   21,435       3,401       24,836       260,715       9.5 %  
Three months ended March 31, 2022   26,979       2,789       29,768       267,657       11.1 %  
Three months ended December 31, 2021   30,932       2,386       33,318       248,226       13.4 %  
Three months ended September 30, 2021   30,481       3,223       33,704       243,384       13.8 %  
Three months ended June 30, 2021   43,721       3,459       47,180       266,005       17.7 %  
 
(1) Beginning in 2023 the definition of Adjusted EBITDA and Adjusted EBITDA margin was updated to exclude the
impact of stock-based compensation.
 

Use of Non-GAAP Financial Measures

In addition to the results reported in accordance with GAAP throughout this release, the Company has provided here or elsewhere information regarding adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”), Adjusted EBITDA margin, adjusted earnings per share (“Adjusted earnings per share” or “Adjusted EPS”), free cash flow, Net Debt, organic revenue, revenue (for the Company and by each reporting segment) excluding acquired businesses and foreign currency translation, revenue excluding foreign currency translation, adjusted operating expenses, pro forma product revenues, pro forma Adjusted EBITDA, pro forma Adjusted EBITDA margin and adjusted effective tax rate, each a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, deferred financing cost amortization, non-cash stock-based compensation expenses, and other gains and losses not reflective of the Company’s ongoing operations and related tax effects including transaction expenses, debt retirement expenses, impairment of assets held for sale, impairment of goodwill, gain or loss on sale of business, restructuring expense, unrealized currency gain or loss and unrealized revaluation of derivatives. Note that in recent prior periods, the Company did not exclude non-cash stock-based compensation expenses in the definition of Adjusted EBITDA. Forward-looking references to Adjusted EBITDA and Adjusted EBITDA margin herein exclude the impact of stock-based compensation as newly defined. The Company defines Adjusted EBITDA margin as Adjusted EBITDA divided by product revenues. The Company defines Adjusted EPS as earnings adjusted by gains and losses not reflective of the Company’s ongoing operations and related tax effects including transaction expenses, debt retirement expenses, impairment of assets held for sale, impairment of goodwill, gain or loss on sale of business, restructuring expense, unrealized currency gain or loss and unrealized revaluation of derivatives. The Company defines Free Cash Flow as Net cash provided by operating activities less Purchases of property and equipment. The Company defines Net Debt as the principal amount of all Consolidated Funded Indebtedness (as defined in the Credit Agreement) less cash and cash equivalents. The Company defines organic revenue as revenue, excluding revenue from acquired businesses. Note that in recent prior periods, the Company used organic revenue instead to be revenue excluding foreign currency translation (see below). The Company defines revenue excluding acquired businesses and foreign currency translation as revenue, excluding the revenue from acquired businesses and the estimated effects of foreign currency exchange on revenue by translating actual revenue using the prior period foreign currency exchange rates. The Company defines revenue excluding foreign currency translation as revenue, excluding the estimated effects of foreign currency exchange on revenue by translating actual revenue using the prior period foreign currency exchange rates. The Company defines adjusted operating expenses as operating expenses excluding impairment of intangible assets and property and equipment, restructuring, related non-cash stock-based compensation, acquisition, integration and divestiture expenses. The Company defines pro forma product revenues as product revenues including the product revenues of Alfmeier as if the acquisition had occurred as of January 1, 2022. The Company defines pro forma Adjusted EBITDA as Adjusted EBITDA, as defined above, including the results of Alfmeier as if the acquisition had occurred as of January 1, 2022. The Company defines pro forma Adjusted EBITDA margin as pro forma Adjusted EBITDA, as defined above, divided by pro forma product revenues. The Company defines adjusted effective tax rate as income tax expense excluding the tax benefit from non-cash goodwill impairment divided by earnings before income tax excluding the impact of non-cash goodwill impairment.

The Company’s reconciliations are included in this release or can be found in the supplemental materials furnished as Exhibit 99.2 to the Company’s Form 8-K dated October 26, 2023.

In evaluating its business, the Company considers and uses Free Cash Flow and Net Debt as supplemental measures of its liquidity and the other non-GAAP financial measures as supplemental measures of its operating performance. Management provides such non-GAAP financial measures so that investors will have the same financial information that management uses with the belief that it will assist investors in properly assessing the Company's performance on a period-over-period basis by excluding matters not indicative of the Company’s ongoing operating or liquidity results and therefore enhance the comparability of the Company's results and provide additional information for analyzing trends in the business. In evaluating our non-GAAP financial measures, you should be aware that in the future we may incur revenues, expenses, and cash and non-cash obligations that are the same as or similar to some of the adjustments in our presentation of non-GAAP financial measures. Our presentation of non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. There also can be no assurance that we will not modify the presentation of our non-GAAP financial measures in the future, and any such modification may be material. Other companies in our industry may define and calculate these non-GAAP financial measures differently than we do and those calculations may not be comparable to our metrics. These non-GAAP measures have limitations as analytical tools, and when assessing the Company's operating performance or liquidity, investors should not consider these non-GAAP measures in isolation, or as a substitute for net income, revenue or other consolidated income statement or cash flow statement data prepared in accordance with GAAP.

Non-GAAP measures referenced in this release and other public communications may include estimates of future Adjusted EBITDA, Adjusted EBITDA margin and Adjusted EPS. The Company has not reconciled the non-GAAP forward-looking guidance included in this release to the most directly comparable GAAP measures because this cannot be done without unreasonable effort due to the variability and low visibility with respect to taxes and non-recurring items, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.

 
GENTHERM INCORPORATED
ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE
(In thousands, except per share data)
(Unaudited)
 
  Three Months Ended
September 30,

  Nine Months Ended
September 30,

 
  2023
  2022
  2023
  2022
 
Net income $ 15,844     $ 9,827     $ 22,256     $ 28,646    
Non-cash purchase accounting impact   1,613       2,842       5,793       6,426    
Restructuring expenses   1,099       6       3,412       561    
Unrealized currency (gain) loss   (898 )     5,308       4,227       (1,032 )  
Acquisition and integration expenses   1,618       11,349       4,730       18,357    
Non-automotive electronics inventory charge   3,426             5,489          
Impairment of goodwill               19,509          
Other   372       (157 )     71       (483 )  
Tax effect of above   (1,693 )     (5,822 )     (8,635 )     (7,020 )  
Adjusted net income $ 21,381     $ 23,353     $ 56,852     $ 45,455    
             
Weighted average shares outstanding:                                
Basic   32,944       33,162       33,049       33,106    
Diluted   33,196       33,470       33,311       33,460    
             
Earnings per share, as reported:                                
Basic $ 0.48     $ 0.30     $ 0.67     $ 0.87    
Diluted $ 0.48     $ 0.29     $ 0.67     $ 0.86    
Adjusted earnings per share:                                
Basic $ 0.65     $ 0.70     $ 1.72     $ 1.37    
Diluted $ 0.64     $ 0.70     $ 1.71     $ 1.36    
 


 
GENTHERM INCORPORATED
CONSOLIDATED CONDENSED BALANCE SHEETS
(In thousands, except share data)
(Unaudited)
 
  September 30, 2023
  December 31, 2022
 
ASSETS                
Current Assets:                
Cash and cash equivalents $ 154,354     $ 153,891    
Accounts receivable, net   263,765       247,131    
Inventory:                
   Raw materials   122,919       136,217    
   Work in process   16,745       17,695    
   Finished goods   66,192       64,336    
Inventory, net   205,856       218,248    
Other current assets   76,651       64,597    
   Total current assets   700,626       683,867    
Property and equipment, net   236,660       244,480    
Goodwill   100,633       119,774    
Other intangible assets, net   66,427       73,933    
Operating lease right-of-use assets   27,442       29,945    
Deferred income tax assets   73,177       69,840    
Other non-current assets   20,632       17,461    
Total assets $ 1,225,597     $ 1,239,300    
LIABILITIES AND SHAREHOLDERS’ EQUITY              
Current Liabilities:              
Accounts payable $ 213,851     $ 182,225    
Current lease liabilities   7,633       7,143    
Current maturities of long-term debt   620       2,443    
Other current liabilities   90,199       93,814    
   Total current liabilities   312,303       285,625    
Long-term debt, less current maturities   207,302       232,653    
Non-current lease liabilities   16,451       20,538    
Pension benefit obligation   3,165       3,638    
Other non-current liabilities   26,324       24,573    
Total liabilities $ 565,545     $ 567,027    
Shareholders’ equity:            
Common Stock:            
   No par value; 55,000,000 shares authorized 32,795,093 and
   33,202,082 issued and outstanding at September 30, 2023 and
   December 31, 2022, respectively
  97,715       122,658    
Paid-in capital   5,379       5,447    
Accumulated other comprehensive loss   (55,955 )     (46,489 )  
Accumulated earnings   612,913       590,657    
Total shareholders’ equity   660,052       672,273    
Total liabilities and shareholders’ equity $ 1,225,597     $ 1,239,300    
 


 
GENTHERM INCORPORATED
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
 
  Nine Months Ended September 30,
 
  2023
  2022
 
Operating Activities:                
Net income $ 22,256     $ 28,646    
Adjustments to reconcile net income to net cash provided by operating
activities:
           
   Depreciation and amortization   38,531       30,470    
   Deferred income taxes   (3,017 )     (1,207 )  
   Stock based compensation   8,451       3,383    
   Loss on disposition of property and equipment   873       620    
   Provisions for inventory   6,597       4,293    
   Impairment of goodwill   19,509          
   Other   81       881    
   Changes in assets and liabilities:            
      Accounts receivable, net   (19,813 )     (55,780 )  
      Inventory   3,733       (53,223 )  
      Other assets   (19,218 )     (10,868 )  
      Accounts payable   32,158       60,983    
      Other liabilities   (10,099 )     4,759    
   Net cash provided by operating activities   80,042       12,957    
Investing Activities:            
Purchases of property and equipment   (26,526 )     (25,737 )  
Proceeds from the sale of property and equipment   72       175    
Acquisition of businesses, net of cash acquired         (224,097 )  
Proceeds from deferred purchase price of factored receivables   10,139       2,168    
Cost of technology investments   (630 )     (350 )  
   Net cash used in investing activities   (16,945 )     (247,841 )  
Financing Activities:            
Repayments of debt   (27,166 )     (11,559 )  
Proceeds from the exercise of Common Stock options   263       1,556    
Taxes withheld and paid on employees' share-based payment awards   (2,754 )     (5,415 )  
Cash paid for the repurchase of Common Stock   (31,094 )        
   Net cash (used in) provided by financing activities   (60,751 )     191,582    
   Foreign currency effect   (1,883 )     (8,141 )  
   Net cash increase (decrease) in cash and cash equivalents   463       (51,443 )  
   Cash and cash equivalents at beginning of period   153,891       190,606    
   Cash and cash equivalents at end of period $ 154,354     $ 139,163    
Supplemental disclosure of cash flow information:            
Cash paid for taxes $ 18,893     $ 13,509    
Cash paid for interest   9,737       3,334    
 

Primary Logo

Source: Gentherm Inc